| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/23/2009 | CA2703425A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | CA2702930A1 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/23/2009 | CA2702837A1 Piperidinyl and piperazinyl modulators of .gamma.-secretase |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2702674A1 Heteroaryl compounds and uses thereof |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2697974A1 Trisubstituted 1,2,4-triazoles |
| 04/22/2009 | EP2050745A1 N-pyridylpiperidine compound, method for producing the same, and pest control agent |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2050467A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049523A1 Modulators of metabolism and the treatment of disorders related thereto |
| 04/22/2009 | EP2049522A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049520A2 Indole compounds |
| 04/22/2009 | EP2049519A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049518A2 Indazole and isoindole derivatives as glucokinase activating agents. |
| 04/22/2009 | EP2049517A1 Amino-piperidine derivatives as cetp inhibitors |
| 04/22/2009 | EP2049516A2 Pharmaceutical compounds |
| 04/22/2009 | EP2049515A2 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis |
| 04/22/2009 | EP2049514A1 Nitrate esters of piperidines |
| 04/22/2009 | EP2049513A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049497A2 Pyrimidine derivatives as hsp90 inhibitors |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049484A1 Isoindoline derivatives for the treatment of arrhythmias |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2049480A1 2-arylindole derivatives as npges-i inhibitors |
| 04/22/2009 | EP2049478A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 04/22/2009 | EP2049475A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049473A2 Substituted benzyl amine compounds |
| 04/22/2009 | EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 04/22/2009 | EP2049120A1 Urotensin ii receptor antagonists |
| 04/22/2009 | EP2049116A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049115A2 Alkyne-substituted pyridone compounds and methods of use |
| 04/22/2009 | EP1934199B1 Indane derivatives as mch receptor antagonists |
| 04/22/2009 | EP1931654B1 Modulators of metabolism and the treatment of disorders related thereto |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2009 | EP1628972B1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 04/22/2009 | EP1592389B1 Piperazine-2-carboxamide derivatives |
| 04/22/2009 | EP1587805B1 Pharmaceutical process and compounds prepared thereby |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | CN101415700A Active ingredient combinations with insecticidal properties |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415683A New compounds |
| 04/22/2009 | CN101415681A Pyridine and pyrimidine derivatives as mGluR2 antagonists |
| 04/22/2009 | CN101415675A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN101412710A Omeprazole sodium compound and preparation thereof |
| 04/22/2009 | CN101412709A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 04/22/2009 | CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/21/2009 | US7521562 Filters for electronic display devices |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2499329C Indole-3-carboxamides as glucokinase (gk) activators |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/16/2009 | WO2009049305A2 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 04/16/2009 | WO2009049132A1 Quinoline derivatives for modulating dna methylation |
| 04/16/2009 | WO2009048765A1 5-ht7 receptor antagonists |
| 04/16/2009 | WO2009048752A2 Insecticidal substituted azinyl derivatives |
| 04/16/2009 | WO2009048751A1 Insecticidal pyrimidinyl aryl hydrazones |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2009047775A2 Polymorphs of esomeprazole salts |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047264A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009047161A1 Chiral cis-imidazolines |
| 04/16/2009 | WO2009046804A1 Imidazole derivatives |
| 04/16/2009 | WO2009046802A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 04/16/2009 | WO2009046784A1 Pyridine derivatives useful as glucokinase activators |
| 04/16/2009 | WO2009021965A3 Substituted quinoline derivatives as h1 receptor antagonists |
| 04/16/2009 | WO2009010660A3 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| 04/16/2009 | WO2008032072A8 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |